UY36208A - “bacterias modificadas para vacunas mejoradas contra la brucelosis”. - Google Patents

“bacterias modificadas para vacunas mejoradas contra la brucelosis”.

Info

Publication number
UY36208A
UY36208A UY0001036208A UY36208A UY36208A UY 36208 A UY36208 A UY 36208A UY 0001036208 A UY0001036208 A UY 0001036208A UY 36208 A UY36208 A UY 36208A UY 36208 A UY36208 A UY 36208A
Authority
UY
Uruguay
Prior art keywords
brucelosis
vaccines against
modified bacteria
inactivated
improved vaccines
Prior art date
Application number
UY0001036208A
Other languages
English (en)
Inventor
Gorvel Jean-Pierre
Arce-Gorvel Vilma
Sean Hanniffy
Conde-Alvarez Raquel
Ignacio Moriyon
Maite Iriarte
Zuniga-Ripa Amaia
Original Assignee
Inserm Inst Nat De La Santé Et De La Rech Médicale
Centre Nat Rech Scient
Université D Aix Marseille
Univ Navarra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inserm Inst Nat De La Santé Et De La Rech Médicale, Centre Nat Rech Scient, Université D Aix Marseille, Univ Navarra filed Critical Inserm Inst Nat De La Santé Et De La Rech Médicale
Publication of UY36208A publication Critical patent/UY36208A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/098—Brucella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1294—Phosphotransferases with paired acceptors (2.7.9)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Abstract

La invención se refiere a una bacteria modificada perteneciente al género Brucella, que porta un gen wadC inactivado y un gen ppdK inactivado, y a usos de la misma. La invención también se refiere a una vacuna contra la brucelosis en humanos y/o animales que comprende una bacteria modificada perteneciente al género Brucella, que porta un gen wadC inactivado y un gen ppdK inactivado
UY0001036208A 2014-07-10 2015-07-09 “bacterias modificadas para vacunas mejoradas contra la brucelosis”. UY36208A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14306125 2014-07-10
EP15305578 2015-04-17

Publications (1)

Publication Number Publication Date
UY36208A true UY36208A (es) 2016-02-29

Family

ID=53539708

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036208A UY36208A (es) 2014-07-10 2015-07-09 “bacterias modificadas para vacunas mejoradas contra la brucelosis”.

Country Status (5)

Country Link
EP (1) EP3166632B1 (es)
CN (2) CN106574235B (es)
ES (1) ES2764173T3 (es)
UY (1) UY36208A (es)
WO (1) WO2016005390A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107058193A (zh) * 2017-06-15 2017-08-18 金宇保灵生物药品有限公司 一种布氏菌病活疫苗s2菌体的高密度发酵方法
MX2020005373A (es) * 2017-11-24 2020-10-19 Consejo Superior Investigacion Cepa vacunal de brucella modificada para el tratamiento de brucelosis.
CN111733097B (zh) * 2020-06-18 2022-07-22 中国兽医药品监察所 一种布鲁氏菌病保护菌株及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100226942A1 (en) * 2008-10-30 2010-09-09 Schurig Gerhardt G Producing an immune response for reducing the risk of developing brucellosis
CN101629151B (zh) * 2009-08-07 2011-08-03 中国农业大学 流产布鲁氏菌免疫标记重组菌株与其在制备疫苗中的应用
CN101629159B (zh) * 2009-08-12 2011-04-20 中国农业大学 流产布鲁氏菌重组菌及其应用
ES2612486T3 (es) * 2009-09-21 2017-05-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Bacterias Gram-negativas modificadas para su uso como vacunas
ES2389066B1 (es) * 2011-03-25 2013-10-30 Instituto Científico Y Tecnológico De Navarra S.A. Método diva de diferenciación de animales vacunados frente a la brucelosis.
CN102327606B (zh) * 2011-09-06 2013-05-01 中国兽医药品监察所 一种布鲁氏菌活疫苗及其生产方法

Also Published As

Publication number Publication date
CN112980761A (zh) 2021-06-18
ES2764173T3 (es) 2020-06-02
EP3166632B1 (en) 2019-12-11
CN106574235B (zh) 2021-03-16
CN106574235A (zh) 2017-04-19
EP3166632A1 (en) 2017-05-17
WO2016005390A1 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
CY1122162T1 (el) Συνθεσεις που περιεχουν bakthpiaka στελεχη
CL2018000432A1 (es) Vacunas terapéuticas contra el hpv18
BR112018003339A2 (pt) anticorpos anti-mesotelina totalmente humanos e células efetoras imunes que visam mesotelelina
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
CR20160502A (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso
BR112016023707A2 (pt) método para produzir l-aminoácidos com o uso de uma bactéria alcalifílica
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
BR112014032636A2 (pt) Vacinas atenuadas de streptococcus suis e métodos de produção e usos das mesmas
CL2019002251A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos.
MX2020004543A (es) Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan.
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
BR112017005524A2 (pt) segmentos de rna viral como agentes imunomoduladores e componentes de vacina
CL2018001279A1 (es) Spodoptera frugiperda resistente a vip3a.
BR112019003992A2 (pt) vacina contra neisseria meningitidis
CY1122473T1 (el) Βελτιστοποιημενο μεσαλαζiνουχο δισκιο υψηλης δοσης
MY180166A (en) Cosmic quenchers
MX2020005584A (es) Vacunacion con particulas de replicon y adyuvante oleoso.
UY36208A (es) “bacterias modificadas para vacunas mejoradas contra la brucelosis”.
CL2016001906A1 (es) Vacunas contra el reovirus aviar.
EP4226937A3 (en) Non-neuroinvasive viruses and uses thereof
MX371363B (es) Metodos de deteccion y cuantificacion de bacterias contenidas en o dentro de goma de mascar.
BR112018013400A2 (pt) vacina marcadora de pestivírus
AR101124A1 (es) Bacterias modificadas para vacunas mejoradas contra la brucelosis
CL2015003616A1 (es) Cepa de piscirickettsia salmonis depositada bajo el numero de registro dms 27338; vacuna que la comprende; uso para prevenir infeccion por p. salmonis; y medio de cultivo para p. salmonis.
NI201800105A (es) Anticuerpos, composiciones y antígenos de chaga, métodos y usos de los mismos.

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20230915